NM_000102.4(CYP17A1):c.1345C>T (p.Arg449Cys) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Aug 31, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002045625.4

Allele description [Variation Report for NM_000102.4(CYP17A1):c.1345C>T (p.Arg449Cys)]

NM_000102.4(CYP17A1):c.1345C>T (p.Arg449Cys)

Gene:
CYP17A1:cytochrome P450 family 17 subfamily A member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q24.32
Genomic location:
Preferred name:
NM_000102.4(CYP17A1):c.1345C>T (p.Arg449Cys)
HGVS:
  • NC_000010.11:g.102830884G>A
  • NG_007955.1:g.11650C>T
  • NM_000102.4:c.1345C>TMANE SELECT
  • NP_000093.1:p.Arg449Cys
  • NC_000010.10:g.104590641G>A
Protein change:
R449C
Links:
dbSNP: rs371825363
NCBI 1000 Genomes Browser:
rs371825363
Molecular consequence:
  • NM_000102.4:c.1345C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002302180Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Aug 31, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular study of five Chinese patients with 46XX partial 17a-hydroxylase/17,20-lyase deficiency.

Tian Q, Yao F, Zhang Y, Tseng H, Lang J.

Gynecol Endocrinol. 2012 Mar;28(3):234-8. doi: 10.3109/09513590.2011.593665. Epub 2011 Aug 16.

PubMed [citation]
PMID:
21846181

A challenging case of primary amenorrhoea.

Sarathi V, Reddy R, Atluri S, Shivaprasad C.

BMJ Case Rep. 2018 Jul 11;2018. doi:pii: bcr-2018-225447. 10.1136/bcr-2018-225447.

PubMed [citation]
PMID:
30002216
PMCID:
PMC6047692
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002302180.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 449 of the CYP17A1 protein (p.Arg449Cys). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individuals with 17-alpha-hydroxylase deficiency (PMID: 21846181, 30002216). ClinVar contains an entry for this variant (Variation ID: 1512295). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant disrupts the p.Arg449 amino acid residue in CYP17A1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 34097983; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024